|
|
|||||||||
Clinical Investigations |
1 Nuclear Cardiology Section, University Hospital, Zurich, Switzerland
2 Department of Nuclear Medicine, University Hospital, Zurich, Switzerland
3 Division of Cardiology, University Hospital, Zurich, Switzerland
ß-Adrenergic blocking agents are widely used in coronary artery disease (CAD), although their impact on myocardial blood flow (MBF) and coronary flow reserve (CFR) remains unclear. We studied the effect of long-term ß-blocker treatment (carvedilol or metoprolol) on coronary microcirculation in CAD patients using PET. Methods: Regional and global resting and adenosine-induced hyperemic MBF and CFR were measured with 13N-ammonia and PET in 36 CAD patients before and after 12 wk of oral therapy with either carvedilol, 50 mg/d, or metoprolol, 100 mg/d. Results: ß-Blockade decreased global resting MBF in proportion to cardiac work (from 0.86 ± 0.20 to 0.77 ± 0.14 mL/min/g, P < 0.05) without affecting global hyperemic flow. Hyperemic MBF was significantly lower in stenosis-dependent segments than in remote segments (1.76 ± 0.64 vs. 2.04 ± 0.67 mL/min/g, P < 0.05) at baseline but was comparable in both after treatment (2.02 ± 0.68 vs. 1.90 ± 0.78 mL/min/g, P = not statistically significant [NS]), resulting in a significant CFR increase in stenotic segments (+15%, P < 0.05) but not in remote segments (+9%, P = NS). Conclusion: The beneficial effect of ß-adrenergic blockade can be explained by the reduction in oxygen consumption (= decreased demand) but also by a modest improvement in vasodilator capacity (= increased supply). The improvement in CFR is found predominantly in stenosis-dependent rather than remote segments.
Key Words: ß-adrenergic blockade coronary artery disease myocardial blood flow PET
Related articles in JNM:
This article has been cited by other articles:
![]() |
R. T. George, A. Arbab-Zadeh, J. M. Miller, K. Kitagawa, H.-J. Chang, D. A. Bluemke, L. Becker, O. Yousuf, J. Texter, A. C. Lardo, et al. Adenosine Stress 64- and 256-Row Detector Computed Tomography Angiography and Perfusion Imaging: A Pilot Study Evaluating the Transmural Extent of Perfusion Abnormalities to Predict Atherosclerosis Causing Myocardial Ischemia Circ Cardiovasc Imaging, May 1, 2009; 2(3): 174 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Zoghbi, T. A. Dorfman, and A. E. Iskandrian The Effects of Medications on Myocardial Perfusion J. Am. Coll. Cardiol., August 5, 2008; 52(6): 401 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schepis, O. Gaemperli, V. Treyer, I. Valenta, C. Burger, P. Koepfli, M. Namdar, I. Adachi, H. Alkadhi, and P. A. Kaufmann Absolute Quantification of Myocardial Blood Flow with 13N-Ammonia and 3-Dimensional PET J. Nucl. Med., November 1, 2007; 48(11): 1783 - 1789. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. George, C. Silva, M. A.S. Cordeiro, A. DiPaula, D. R. Thompson, W. F. McCarthy, T. Ichihara, J. A.C. Lima, and A. C. Lardo Multidetector Computed Tomography Myocardial Perfusion Imaging During Adenosine Stress J. Am. Coll. Cardiol., July 4, 2006; 48(1): 153 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lautamaki, K.E. J. Airaksinen, M. Seppanen, J. Toikka, R. Harkonen, M. Luotolahti, R. Borra, J. Sundell, J. Knuuti, and P. Nuutila Insulin Improves Myocardial Blood Flow in Patients With Type 2 Diabetes and Coronary Artery Disease Diabetes, February 1, 2006; 55(2): 511 - 516. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |